Kamel Metwally

1.0k total citations · 1 hit paper
39 papers, 728 citations indexed

About

Kamel Metwally is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Kamel Metwally has authored 39 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 17 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Kamel Metwally's work include Synthesis and biological activity (14 papers), Quinazolinone synthesis and applications (10 papers) and Aldose Reductase and Taurine (4 papers). Kamel Metwally is often cited by papers focused on Synthesis and biological activity (14 papers), Quinazolinone synthesis and applications (10 papers) and Aldose Reductase and Taurine (4 papers). Kamel Metwally collaborates with scholars based in Egypt, Saudi Arabia and Greece. Kamel Metwally's co-authors include Galal Yahya, Simona Cavalu, Harris Pratsinis, Dimitris Kletsas, Lobna M. Abdel‐Aziz, Mohamed I. Husseiny, Richard A. Glennon, Milt Teitler, Maƚgorzata Dukat and Mohamed El‐Sadek and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Kamel Metwally

35 papers receiving 708 citations

Hit Papers

Emerging Role of GLP-1 Agonists in Obesity: A Comprehensi... 2023 2026 2024 2025 2023 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Emerging Role of GLP-1 Agonists in Obesity: A Comprehensive Review of Randomised Controlled Trials
    2023 136 citations Galal Yahya, Kamel Metwally et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kamel Metwally Egypt 15 304 227 108 105 58 39 728
Shashwat Sharad United States 14 403 1.3× 241 1.1× 172 1.6× 30 0.3× 37 0.6× 26 956
Reza Ahmadi Iran 19 124 0.4× 275 1.2× 58 0.5× 51 0.5× 102 1.8× 61 871
Hai‐Bin Gong China 20 469 1.5× 433 1.9× 82 0.8× 34 0.3× 49 0.8× 43 1.4k
Rajiv Kumar Tonk India 12 179 0.6× 381 1.7× 51 0.5× 21 0.2× 59 1.0× 45 852
Yu Nakashima Japan 18 157 0.5× 477 2.1× 324 3.0× 37 0.4× 63 1.1× 73 991
Marco Migliore United States 12 94 0.3× 148 0.7× 184 1.7× 34 0.3× 50 0.9× 19 469
Rasha A. Nassra Egypt 14 314 1.0× 183 0.8× 133 1.2× 22 0.2× 94 1.6× 31 623
Katrin Fischer Germany 18 224 0.7× 493 2.2× 437 4.0× 149 1.4× 139 2.4× 36 1.0k
Xiaojun Gou China 17 194 0.6× 353 1.6× 64 0.6× 17 0.2× 40 0.7× 38 800
Tae‐Sung Koo South Korea 17 65 0.2× 235 1.0× 84 0.8× 34 0.3× 31 0.5× 60 702

Countries citing papers authored by Kamel Metwally

Since Specialization
Citations

This map shows the geographic impact of Kamel Metwally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamel Metwally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamel Metwally more than expected).

Fields of papers citing papers by Kamel Metwally

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamel Metwally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamel Metwally. The network helps show where Kamel Metwally may publish in the future.

Co-authorship network of co-authors of Kamel Metwally

This figure shows the co-authorship network connecting the top 25 collaborators of Kamel Metwally. A scholar is included among the top collaborators of Kamel Metwally based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamel Metwally. Kamel Metwally is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Metwally, Kamel, Galal Yahya, & Nader E. Abo‐Dya. (2025). Drugging the undruggable: Chemical and biological insights into molecular glues in the pipeline. European Journal of Medicinal Chemistry. 300. 118132–118132.
2.
3.
Rahim, Kashif, Ihtisham Ul Haq, Muhammad Nawaz, et al.. (2024). Revolutionizing Treatment Strategies for Autoimmune and Inflammatory Disorders: The Impact of Dipeptidyl-Peptidase 4 Inhibitors. Journal of Inflammation Research. Volume 17. 1897–1917. 2 indexed citations
4.
Abdullah, Abdullah, et al.. (2024). Recent Advances in the Development of Metal/Metal Oxide Nanoparticle and Antibiotic Conjugates (MNP–Antibiotics) to Address Antibiotic Resistance: Review and Perspective. International Journal of Molecular Sciences. 25(16). 8915–8915. 10 indexed citations
5.
Yahya, Galal, et al.. (2023). Emerging Role of GLP-1 Agonists in Obesity: A Comprehensive Review of Randomised Controlled Trials. International Journal of Molecular Sciences. 24(13). 10449–10449. 136 indexed citations breakdown →
6.
Metwally, Kamel, Nader E. Abo‐Dya, Mohammed Issa Alahmdi, et al.. (2023). The Unusual Architecture of RNA-Dependent RNA Polymerase (RdRp)’s Catalytic Chamber Provides a Potential Strategy for Combination Therapy against COVID-19. Molecules. 28(6). 2806–2806. 3 indexed citations
7.
Pijuan, Jordi, David F. Moreno, Galal Yahya, et al.. (2023). Regulatory and pathogenic mechanisms in response to iron deficiency and excess in fungi. Microbial Biotechnology. 16(11). 2053–2071. 16 indexed citations
8.
Metwally, Kamel, Nader E. Abo‐Dya, Ahmed M. Hamdan, et al.. (2023). Investigation of Simultaneous and Sequential Cooperative Homotropic Inhibitor Binding to the Catalytic Chamber of SARS-CoV-2 RNA-dependent RNA Polymerase (RdRp). Cell Biochemistry and Biophysics. 81(4). 697–706.
9.
Popoviciu, Mihaela Simona, et al.. (2023). Diabetes Mellitus Secondary to Endocrine Diseases: An Update of Diagnostic and Treatment Particularities. International Journal of Molecular Sciences. 24(16). 12676–12676. 26 indexed citations
10.
11.
Abou‐Elkhair, Reham A. I., et al.. (2020). 2-Hydroxyimino-6-aza-pyrimidine nucleosides: synthesis, DFT calculations, and antiviral evaluations. New Journal of Chemistry. 44(45). 19650–19662. 2 indexed citations
12.
Jiménez, Rafael, Júlia Lorenzo, Kamel Metwally, et al.. (2019). Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: Kinetic characterization and effect on human cancer cells. Chemico-Biological Interactions. 306. 123–130. 20 indexed citations
13.
Metwally, Kamel, et al.. (2017). Synthesis and anticancer activity of novel quinazolinone-based rhodanines. Chemistry Central Journal. 11(1). 102–102. 31 indexed citations
14.
Metwally, Kamel, Lobna M. Abdel‐Aziz, Ahmed A. El‐Rashedy, et al.. (2017). Quinazolinone-based rhodanine-3-acetic acids as potent aldose reductase inhibitors: Synthesis, functional evaluation and molecular modeling study. Bioorganic & Medicinal Chemistry Letters. 27(20). 4760–4764. 23 indexed citations
15.
Abdel‐Aziz, Mohamed, Kamel Metwally, Amira M. Gamal‐Eldeen, & Omar M. Aly. (2015). 1,3,4-oxadiazole-2-thione Derivatives; Novel Approach for Anticancer and Tubulin Polymerization Inhibitory Activities. Anti-Cancer Agents in Medicinal Chemistry. 16(2). 269–277. 14 indexed citations
16.
Metwally, Kamel, Ashraf Khalil, Harris Pratsinis, & Dimitris Kletsas. (2010). Synthesis, in‐vitro Cytotoxicity, and a Preliminary Structure‐Activity Relationship Investigation of Pyrimido[4,5‐c]quinolin‐1(2H)‐ones. Archiv der Pharmazie. 343(8). 465–472. 7 indexed citations
17.
Metwally, Kamel, et al.. (2007). Synthesis and biological activity of 2,5-diaryl-3-methylpyrimido[4,5-c]quinolin-1(2H)-one derivatives. Bioorganic & Medicinal Chemistry. 15(6). 2434–2440. 7 indexed citations
18.
Metwally, Kamel, et al.. (2006). Hydrazones of 2-aryl-quinoline-4-carboxylic acid hydrazides: Synthesis and preliminary evaluation as antimicrobial agents. Bioorganic & Medicinal Chemistry. 14(24). 8675–8682. 107 indexed citations
19.
Metwally, Kamel, Harris Pratsinis, & Dimitris Kletsas. (2006). Pyrimido[4,5-c]quinolin-1(2H)-ones as a novel class of antimitotic agents: Synthesis and in vitro cytotoxic activity. European Journal of Medicinal Chemistry. 42(3). 344–350. 12 indexed citations
20.
Glennon, Richard A., Kamel Metwally, Maƚgorzata Dukat, et al.. (2002). Ketanserin and Spiperone as Templates for Novel Serotonin 5-HT2A Antagonists. Current Topics in Medicinal Chemistry. 2(6). 539–558. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shashwat Sharad Breakdown of academic impact, for papers by Reza Ahmadi Breakdown of academic impact, for papers by Hai‐Bin Gong Breakdown of academic impact, for papers by Rajiv Kumar Tonk Breakdown of academic impact, for papers by Yu Nakashima Breakdown of academic impact, for papers by Marco Migliore Breakdown of academic impact, for papers by Rasha A. Nassra Breakdown of academic impact, for papers by Katrin Fischer Breakdown of academic impact, for papers by Xiaojun Gou Breakdown of academic impact, for papers by Tae‐Sung Koo
Rankless by CCL
2026